… the discrepancy – or what drugmakers call the "pill … could have huge implications for drugmakers, patients and Medicare… other proposals that the pharmaceutical industry has strongly opposed.  … -facing persona. To some degree, the company's …

… major drugmakers hold either a PhD or an MD degree.  Still … , a recent review of leaders at Big Pharma … in STEM Phd fields.  Pharma, biotech recruitment consideration In … for client recruitment.  In pharma and biotech, this experience can …

… trading partners. For the pharmaceutical industry, the implications are … to decrease U.S. drugmakers’ long-standing reliance on … replicated, requiring a high degree of collaboration along supply chains … has a master’s degree in mechanical engineering from …

… involves transporting temperature-sensitive pharmaceutical products. Even small changes … of even a few degrees can spoil the product. … language models can enable drugmakers to better interrogate data … parties are fragmented and drugmakers are forced to rely …

… ; plans national registry “Pharmacy Council of India may … and degree institutions were granted approval under the Pharmacy Act, … degree, Pharm.D., M.Pharm and B.Pharm (Practice) institutions. For pharmacy … read | For small drugmakers playing fast and loose …

… Officer (CFO). As the drugmakers CFO, Pillai will oversee … as telecom, technology, education, pharmaceuticals, and manufacturing. In terms … a First-Class Postgraduate Degree from the University of … K. Masurkar, CEO, ENTOD Pharmaceuticals. Published On Mar 18, …

… -net hospitals or contracting pharmacies in 340B locations. Using … more challenging. Meanwhile, the drugmakers suggested a rebate plan. … Mulligan added. Several other drugmakers followed suit, developing rebate plans … a master's degree from NYU's …

… although special interests like the pharma lobby have been fighting … and more a matter of degree. President Trump will still … , Sclafani said. While some drugmakers have estimated a negative impact … Sclafani said. As for pharma’s persistent argument that price …

… Pharma companies.  Looking around the C-suites of major drugmakers … level positions at major pharmaceutical companies with significant … Akintade earned his medical degree in London and holds … across oncology, vaccines, pharmaceutical and pipeline products.  He …

… -intelligence boom, drugmakers were left behind, with pharma stocks trading at … influence in Washington, the pharma lobby suffered a major blow … s optimism may reflect a degree of wishful thinking, it … policy. The NYSE Arca Pharmaceutical Index isn’t exactly a …